Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2025-12-24 @ 9:57 PM
NCT ID:
NCT06984432
Brief Summary:
The goal of this clinical investigation is to learn whether injectable implants based on non-cross-linked hyaluronic acid (Electri and XELA REDERM) improve the aesthetic appearance of facial skin in adult women. It will also learn about the safety of these medical devices.
The main questions it aims to answer are:
Does skin appearance improve after a series of redermalization procedures? How do the procedures affect skin hydration and elasticity? What side effects or medical issues, if any, do participants experience? Researchers did not use a control group. Instead, they evaluated skin improvements in the same participants over time.
Participants:
Received 3 injections of the hyaluronic acid-based device over 6 weeks (1 injection every 14±1 days).
Had their skin condition assessed by doctors and by themselves using a standardized scale.
Underwent tests to measure skin hydration and elasticity. Reported any adverse events or adverse device effects.
Study:
NCT06984432
Study Brief:
Protocol Section:
NCT06984432